Secondary CNS tumours in children initially treated from ALL according to the treatment protocols of chemotherapy and radiotherapy

1 КЗ ЛОР «Західноукраїнський спеціалізований дитячий медичний центр», м. Львів, Україна 2 Львівський національний медичний університет імені Данила Галицького, м. Львів, Україна 3 Інститут та поліклініка діагностичної та інтервенційної нейрорадіології, м. Дрезден, Федеративна Республіка Німеччина 4 Університетська клініка Carl Gustav Carus, м. Дрезден, Федеративна Республіка Німеччина 5 Технічний університет, м. Дрезден, Федеративна Республіка Німеччина 6 Інститут публічного права Вільної Саксонії, м. Дрезден, Федеративна Республіка Німеччина 7 Центр медичних інновацій «NOVO», м. Львів, Україна УДК: 616.831 006 053.2 + 615.849.1]:616 006.446.2 036.11

[1]  R. Corvò,et al.  Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Berger,et al.  Radiation-induced meningiomas in pediatric patients. , 1988, Neurosurgery.

[3]  Y. Bertrand,et al.  Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours , 2011, Pediatric blood & cancer.

[4]  J. Wachowiak,et al.  Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[5]  R. Weinshilboum,et al.  Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. , 2009, Blood.

[6]  D. Green,et al.  Late effects of treatment for childhood cancer , 1992 .

[7]  A. Yeoh,et al.  A report from the Singapore Childhood Cancer Survivor Study (SG-CCSS): a multi-institutional collaborative study on long-term survivors of childhood cancer, initial analysis reporting for the SG-CCSS. , 2009, Annals of the Academy of Medicine, Singapore.

[8]  K. Abdullah,et al.  Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study , 2017, Pediatric Neurosurgery.

[9]  M. Schrappe,et al.  Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. , 2000, Blood.

[10]  A. Meadows,et al.  INCIDENCE OF SECOND MALIGNANT NEOPLASMS IN CHILDREN: RESULTS OF AN INTERNATIONAL STUDY , 1982, The Lancet.

[11]  A. Kuten,et al.  Case report: late aggressive meningioma following prophylactic cranial irradiation for acute lymphoblastic leukaemia. , 1995, The British journal of radiology.

[12]  M. Guiney,et al.  Secondary tumours after prophylactic cranial irradiation. , 1996, Australasian radiology.

[13]  L. Robison,et al.  Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. , 2002, Blood.

[14]  T. Siegal,et al.  Intracranial meningiomas after high‐dose irradiation , 1989, Cancer.

[15]  Matthew A. Scoggins,et al.  Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Henze,et al.  Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. , 2008, European journal of cancer.

[17]  F. Behm,et al.  L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. , 1995, Leukemia.

[18]  M. Rivarola,et al.  Evaluation of Gonadal Function Following Long‐Term Treatment for Acute Lymphoblastic Leukemia in Girls , 1987, The American journal of pediatric hematology/oncology.

[19]  M. Malone,et al.  Astrocytoma as a second malignancy in patients with acute lymphoblastic leukemia , 1986, Cancer.

[20]  K. Newell,et al.  Secondary intracranial neoplasms exhibiting features of astrocytoma and neuroblastoma in 2 children treated for acute lymphoblastic leukemia: report of 2 cases. , 2006, Surgical neurology.

[21]  W. Badowska,et al.  Health status of Polish children and adolescents after cancer treatment , 2017, European Journal of Pediatrics.

[22]  K. Ness,et al.  Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues , 2009, Cancer.

[23]  F. Behm,et al.  Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. , 2003, Blood.

[24]  F. Behm,et al.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.

[25]  G. Draper,et al.  Incidence of second primary tumours among childhood cancer survivors. , 1987, British Journal of Cancer.

[26]  J. Olsen,et al.  Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. , 2007, Journal of the National Cancer Institute.

[27]  S. Sallan,et al.  Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13‐year experience from the Dana‐Farber cancer institute and the children's hospital , 1987, Cancer.

[28]  R. Schachar,et al.  Brain structure, working memory and response inhibition in childhood leukemia survivors , 2016, Brain and behavior.

[29]  W. El-Deiry,et al.  Childhood ALL and second neoplasms , 2007, Cancer biology & therapy.

[30]  R. Aur,et al.  Endocrine assessment in childhood acute lymphocytic leukemia , 1982 .

[31]  Yan Liu,et al.  New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2006, Journal of the National Cancer Institute.

[32]  L. Robison,et al.  Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.

[33]  L. Todorovski,et al.  Classification tree analysis of second neoplasms in survivors of childhood cancer , 2007, BMC Cancer.

[34]  Pica in a Child with Anterior Cingulate Gyrus Oligodendroglioma: Case Report , 2017, Pediatric Neurosurgery.

[35]  C. Tseng,et al.  Oligodendrogliomas in Children: Clinical Experiences With 20 Patients , 2016, Journal of pediatric hematology/oncology.

[36]  M. Relling,et al.  High incidence of secondary brain tumours after radiotherapy and antimetabolites , 1999, The Lancet.

[37]  S. Nussey,et al.  Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. , 2017, The Lancet. Oncology.

[38]  H. Ekert,et al.  Cognitive and academic outcome following cranial irradiation and chemotherapy in children: a longitudinal study , 2000, British Journal of Cancer.

[39]  M. Feinmesser,et al.  High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.

[40]  F. Mandelli,et al.  Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia , 1987, Cancer.

[41]  F. Berthold,et al.  Case–control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany , 2009, Cancer Causes & Control.

[42]  S. Bhatia,et al.  Late effects of childhood cancer and its treatment. , 2015, Pediatric clinics of North America.

[43]  D. Poplack,et al.  Memory and Learning Sequelae in Long‐term Survivors of Acute Lymphoblastic Leukemia: Association with Attention Deficits , 1990, The American journal of pediatric hematology/oncology.

[44]  P. Zieliński,et al.  Poor-risk high-grade gliomas in three survivors of childhood acute lymphoblastic leukaemia—an overview of causative factors and possible therapeutic options , 2009, Child's Nervous System.

[45]  M. Kubota,et al.  Second malignancy following treatment of acute lymphoblastic leukemia in children. , 1998, International journal of hematology.

[46]  R. Matsuda,et al.  [High-dose radiation-induced meningioma following prophylactic cranial irradiation for acute lymphoblastic leukaemia]. , 2005, No shinkei geka. Neurological surgery.

[47]  T. Loddenkemper,et al.  Seizures caused by brain tumors in children , 2017, Seizure.

[48]  D. Solomon,et al.  Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature , 2017, Pediatric blood & cancer.

[49]  L. Robison,et al.  Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[50]  N R Schneider,et al.  Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S. Pai,et al.  Brain tumors following cure of acute lymphoblastic leukemia. , 1994, Leukemia & lymphoma.

[52]  K. Trott.  Special radiobiological features of second cancer risk after particle radiotherapy. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[53]  W. Wallace,et al.  The impact of long-term follow-up care for childhood cancer survivors: A systematic review. , 2017, Critical reviews in oncology/hematology.

[54]  B. Wörmann,et al.  Late Effects and Long-Term Follow-Up after Cancer in Childhood , 2017, Oncology Research and Treatment.

[55]  H. Burger,et al.  Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. , 1989, The New England journal of medicine.

[56]  P. Nathan,et al.  Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. , 2014, The Lancet. Oncology.